sciencePeptideDosage

What Is NAD+? The Molecule and the Vial

What is NAD+ has two answers: a coenzyme every cell already makes, and a vial holding hundreds of milligrams. Only the second one has arithmetic to check.

verifiedMedically reviewed byMichael Bre, MD
eventLast reviewed
warning

MEDICAL DISCLAIMER: Educational research guidelines only. Lyophilized peptides are investigational chemical compounds and are NOT approved for human consumption, diagnosis, or therapy. Consult a licensed physician before any research application.

What is NAD+ depends on which of two objects the question means. As a molecule, nicotinamide adenine dinucleotide is a coenzyme that cells already make and use in energy metabolism. It is not a synthetic peptide, and nobody designed it. As a purchase, it is a glass vial carrying a printed mass that is usually in the hundreds of milligrams, and that printed mass is the only part of the object arithmetic can touch.

This page keeps the two apart, because conflating them is how a settled piece of biochemistry gets used to vouch for an unverified container. The biochemistry is not in dispute. The vial is a different matter, and it forces numbers unlike anything else covered on this site, where every other compound arrives in single milligrams.

Lowest cost per milligram we track

NAD+ — Ascension Peptides

Independently assayed research material. With the code the 1,000 mg vial works out at $5.20 per 100 mg.

NAD+ · 1,000 mg$104.00$52.00$5.20 per 100 mgGet the 1,000 mg →

Quoted per 100 mg because NAD+ is dosed in hundreds of milligrams, not the single milligrams a peptide vial holds. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price. Free shipping starts at $250.

  • Two third-party assays per batch
  • Free carriage over $250
  • Same-day dispatch before 2pm CST
Discount codePEPTIDEDECK−50%

What is NAD+ once the question moves from biochemistry to the bench

QuestionThe coenzymeThe vial on sale
OriginBuilt inside cells from dietary precursorsManufactured powder sold as a research chemical
Amount in playAn internal concentration, not an amount anyone administersA printed mass, commonly in the hundreds of milligrams
What establishes itLong settled biochemistryA seller's label, unverified without an independent assay
Measurable at homeNothingVolume added, volume drawn, and every ratio between them
Regulatory positionNot applicable to a moleculeNo marketing authorisation anywhere for injected NAD+

The left column is why the compound sounds familiar and safe. The right column is what actually gets bought. Nothing in the left column certifies the right one: a molecule the body already handles can still arrive in a vial whose contents nobody has measured, at a concentration nobody wrote down.

A thousand milligrams behaves nothing like five

The rest of this site works with vials holding 5 or 10 mg, where a draw is a small fraction of a syringe barrel. NAD+ inverts that. Here is the same conversion chain run at both scales, on a U-100 syringe where one unit is 0.01 mL.

Labelled massWater addedConcentrationMass in one unitUnits holding 50 mg
5 mg2 mL2.5 mg per mL25 mcg2,000 units, twenty full barrels
500 mg5 mL100 mg per mL1 mg50 units
500 mg10 mL50 mg per mL0.5 mg100 units, one full barrel
1000 mg10 mL100 mg per mL1 mg50 units
1000 mg5 mL200 mg per mL2 mg25 units

Read the fourth column. On a typical peptide vial a single unit carries micrograms, so the syringe scale is far finer than the amounts in question and rounding to the nearest graduation costs almost nothing. On a 1000 mg NAD+ vial at 100 mg per mL, a single unit carries a whole milligram. One graduation misread is a milligram gone, which on a peptide vial would be the entire contents several times over.

The last column matters for a different reason. Barrel capacity stops being theoretical. At 50 mg per mL an amount of 50 mg fills the barrel completely, so anything larger needs more than one draw or a larger syringe. That constraint never arises at 2.5 mg per mL, and it catches people who carried habits across from a 5 mg vial.

Solid volume is negligible at 5 mg and is not at 1000

There is a second scale effect, and it is the one most often missed. Concentration is usually computed as labelled mass divided by water added. That treats the powder as occupying no space. At 5 mg the approximation is harmless. At 1000 mg it is not.

Take an assumed solid density of 1.5 g per mL. The density is an assumed input, stated here so the arithmetic can run, not a measured property of any particular product. One gram of solid at that density occupies about 0.67 mL. Add 10 mL of water and the final volume is roughly 10.67 mL, not 10. The true concentration is 1000 divided by 10.67, about 93.7 mg per mL, where the label arithmetic said 100. That is an overstatement of roughly one part in fifteen, and it runs through every draw taken from that vial.

Run the same assumption on a 5 mg peptide vial and the solid occupies about 0.003 mL against 2 mL of water, an effect near one part in six hundred. Invisible, correctly ignored.

The fix is a change of method rather than a correction factor. If the container is graduated, reconstitute to a final volume and read the mark, rather than adding a measured volume of water and assuming the total. Then the denominator is observed instead of inferred, and the assumed density drops out of the calculation entirely.

The intervention people buy and the intervention people study

The literature attached to this molecule is enormous, and it is mostly not about the thing in the vial. The bulk of the interventional human work studies NAD precursors, principally nicotinamide riboside and nicotinamide mononucleotide, given orally in tablet or capsule form. Those are the trials in humans. Injected NAD+ is a different intervention with a much thinner record, and a claim sourced from a precursor trial does not carry over to it without saying so.

That distinction has to survive into every sentence. Writing that NAD+ has been studied extensively in humans is misleading when the studies were of an oral precursor. Naming the intervention costs four words and preserves the whole meaning.

Writing the precursor conversion as an equation

The natural next question is whether an oral precursor amount can be converted into an injected NAD+ amount. Write it out and the answer becomes visible without any biology.

An equivalent injected mass would be the oral precursor mass multiplied by the fraction absorbed from the gut, multiplied by the fraction converted onward into NAD+, multiplied by whatever term relates an oral route to an injected one. That is one known quantity and three unknowns. No published figure is cited here for any of the three, because none is being asserted.

A calculator will still produce an answer if someone guesses those fractions, and the answer will look as precise as every other number on this page. It is not the same kind of number. The conversions in the tables above are definitional: a unit is a volume, a concentration is a ratio, and division cannot be wrong about them. The precursor conversion is an empirical claim wearing arithmetic as a costume.

Cost expressed per hundred milligrams

Per milligram is the wrong unit here. On a 500 mg vial it produces a figure with too many leading zeros to compare at a glance, so quote per 100 mg instead: for a vial priced at P, that is P divided by five. For a 1000 mg vial at price Q, it is Q divided by ten. The larger vial is the better value per 100 mg only when Q is less than twice P, which is worth checking rather than assuming.

The comparison also has to survive the water clock. Bacteriostatic water is generally treated as giving a preserved solution roughly four weeks of use. Suppose a 1000 mg vial at 100 mg per mL is drawn in 50 mg portions, which is 20 draws, and take an every other day interval purely as an arithmetic input rather than as any suggested pattern. Fourteen of those draws fall inside a 28 day window and six do not. Seven hundred milligrams gets used, so the real figure is Q divided by seven per used 100 mg, not Q divided by ten. Buying the larger container improved the shelf price and worsened the delivered one.

Frequently Asked Questions

Is injected NAD+ the same intervention as an NMN capsule?expand_more

No. Nicotinamide mononucleotide is a precursor taken by mouth and converted in the body. Injected NAD+ skips both steps. They are related molecules and different interventions, and the human trial evidence sits mainly with the oral precursors.

Does a bigger labelled mass mean a stronger preparation?expand_more

Not by itself. Strength is concentration, which is mass divided by fill volume. A 1000 mg vial in 10 mL and a 500 mg vial in 5 mL both come out at 100 mg per mL. The larger vial holds more material, not more per millilitre.

Why does this compound need a graduated container?expand_more

Because at hundreds of milligrams the powder displaces enough liquid to shift the concentration by a noticeable fraction. Reconstituting to a marked final volume measures the denominator instead of assuming it.

Can the vial label be trusted as a mass?expand_more

It is a claim by a seller, not a measurement, and there is no marketing authorisation for injected NAD+ anywhere to sit behind it. Every derived figure inherits whatever error the label carries, which is why the arithmetic on this page is precise about the ratios and silent about the absolute amounts.

What would have to be published for injected NAD+ to be judged on its own?expand_more

Controlled human trials of the injected form, reported separately from the oral precursor literature, plus independent assay data on commercially sold vials. The first would fix what the intervention does. The second would fix what is in the container. Neither can be replaced by division.